Abstracts

Periodically intensification during maintenance chemotherapy is effective in pediatric acute lymphoblastic leukemia
Flow cytometric detection of Acute Lymphoblastic Leukemia in CSF and its role in predicting survival and neurotoxicity in pediatrics at King Abdulaziz Medical City in Jeddah, Saudi Arabia – A retrospective study
Pediatric Hodgkin Lymphoma: Real World Data Over 15 Years from a Regional Cancer Centre in South India
Financial Costs of Pediatric Cancer Management in Africa: Systematic Review and Meta-Analysis
Paediatric Rhabdomyosarcoma: 15-Year Experience From A Regional Cancer Centre In South India
Early Experience Using the Cog ARET0321 Protocol for the Treatment of International Retinoblastoma Staging System (IRSS) 3 in a Resource-Limited Setting
Genetic testing for cancer predisposition syndromes in pediatric oncology: A single center experience
CD19 Chimeric Antigen Receptor (CAR) T- Cell therapy with Tisagenlecleucel in Children with B-Cell Acute Lymphoblastic Leukemia: Preliminary Findings from a Tertiary Care Center
GLI1-Altered Mesenchymal Tumors in Pediatric Patients: A Clinical, Morphological and Molecular Analysis of Four Cases
The Prevalence and Associated Risk Factors for Neonatal Thrombocytopenia Among Newborns Admitted to the Neonatal Intensive Care Unit
Possibilities of Using the Systemic Immune-Inflammation Index in the Diagnosis, Treatment, and Prognosis of Pediatric Patients with Hodgkin’s Lymphoma During Puberty
Referral Patterns, Time-To-Diagnosis (TTD), and Time-To-Treatment Initiation (TTI) in Children with Cancer: Experience from a Tertiary Care Center, King Faisal Specialist Hospital and Research Centre , Madinah, Saudi Arabia